CD79a (B-Cell Marker); Clone JCB117 & HM47/A9 (Concentrate)

Specificity: Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20). This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well.
Immunogen: A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein (JCB117 and HM47/A9).

• SKU: SCYRA0071-C.1
• Manufacturer: ScyTek Laboratories
• Manufacturer SKU: RA0071-C.1
• Package Unit: 0,1 ml
• Quantity Unit: STK
• Reactivity: Human, Mouse (Murine), Rat (Rattus), Pig (Porcine), Monkey (Primate), Cow (Bovine)
• Isotype: IgG1
• Host: Mouse